Clinical Trials Directory

Trials / Completed

CompletedNCT03265184

Green Coffee Extract Supplementation and Oxidative Stress, Systemic and Vascular Inflammation

Effects of Green Coffee Extract Supplementation on Oxidative Stress, Systemic and Vascular Inflammation in Patients With Metabolic Syndrome: A Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
National Nutrition and Food Technology Institute · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Metabolic syndrome (Mets) is defined as the collection of risk factors contributing to type 2 diabetes mellitus and cardiovascular disease. Mets is accompanied by oxidative stress and low-grade inflammation. Green coffee is rich in polyphenols called chlorogenic acids (CGA) which possess anti-inflammatory and anti-oxidative characteristics. Thus, we carried out this trial to examine green coffee extract (GCE) effects on oxidative stress, systemic and vascular inflammation in patients having Mets

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTgreen coffee extractPatients in treatment group take 400 mg GCE supplements twice a day for tow month

Timeline

Start date
2017-01-01
Primary completion
2017-06-12
Completion
2017-07-18
First posted
2017-08-29
Last updated
2017-08-29

Source: ClinicalTrials.gov record NCT03265184. Inclusion in this directory is not an endorsement.